Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 03, 2025 Filed Jun 4, 2025 21:36 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 1,860 $71.50 $132,990.00
Disclosure

SEC source: 0001628280-25-029406 · wk-form4_1749073009.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,323

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 21:36 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 1,579 $71.50 $112,898.50
Disclosure

SEC source: 0001628280-25-029405 · wk-form4_1749072980.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,288

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:42 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 1,642 $71.50 $117,403.00
Disclosure

SEC source: 0001628280-25-029372 · wk-form4_1749069723.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,579

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:40 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 5,472 $71.50 $391,248.00
Disclosure

SEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 5

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 308,758

F5 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 20:41 UTC SaleCommon Stock 3,250 $71.30 $231,725.00
Disclosure

SEC source: 0001628280-25-029370 · wk-form4_1749069680.xml · nonDerivative · entry 1

MCGIRR DAVID W J · CIK 0001219023 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,723

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 3,250 shares sold at prices ranging from $71.09 to $71.54 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:40 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,830 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · derivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 157,160

Underlying: Common Stock · 6,830 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:40 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 1,430 $71.94 $102,874.20
Disclosure

SEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 233,924

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 1,430 shares sold at prices ranging from $71.67 to $72.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:40 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 4,400 $71.35 $313,940.00
Disclosure

SEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 235,354

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 4,400 shares sold at prices ranging from $70.67 to $71.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:40 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 1,000 $70.23 $70,230.00
Disclosure

SEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 239,754

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 1,000 shares sold at prices ranging from $69.59 to $70.57 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:40 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 6,830 $10.85 $74,105.50
Disclosure

SEC source: 0001628280-25-029368 · wk-form4_1749069612.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:02 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 20,000 $70.00 $1,400,000.00
Disclosure

SEC source: 0001628280-25-029012 · wk-form4_1748980929.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,045

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 20,000 shares sold at prices ranging from $70.00 to $70.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:02 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 6,327 $68.56 $433,779.12
Disclosure

SEC source: 0001628280-25-029012 · wk-form4_1748980929.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,045

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 6,327 shares sold at prices ranging from $68.13 to $68.88 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 27, 2025 Filed May 29, 2025 20:46 UTC GiftCommon Stock 200 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028379 · wk-form4_1748551609.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,616

Read SEC document
May 21, 2025 Filed May 22, 2025 21:20 UTC PurchaseCommon Stock 1,130 $66.35 $74,975.50
Disclosure

SEC source: 0001628280-25-027340 · wk-form4_1747948827.xml · nonDerivative · entry 2

Desjardins Clarissa · CIK 0001793390 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 3,025

Read SEC document
May 20, 2025 Filed May 22, 2025 21:22 UTC GiftCommon Stock 100 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 5

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Melvin Sharoky C/F Wren J. Sharoky UTMA/FL

Disclosed balance after: 100

F4 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Wren J. Sharoky UTMA/FL.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:22 UTC GiftCommon Stock 100 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 4

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Melvin Sharoky C/F Leo J. Sharoky UTMA/FL

Disclosed balance after: 100

F3 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Leo J. Sharoky UTMA/FL.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:22 UTC GiftCommon Stock 100 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Melvin Sharoky C/F Violet A. Paley UTMA/FL

Disclosed balance after: 100

F2 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Violet A. Paley UTMA/FL.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:22 UTC GiftCommon Stock 100 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Melvin Sharoky C/F Owen F. Paley UTMA/FL

Disclosed balance after: 100

F1 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Owen F. Paley UTMA/FL.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:22 UTC GiftCommon Stock 400 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-027344 · wk-form4_1747948965.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,816

Read SEC document
May 20, 2025 Filed May 22, 2025 21:20 UTC PurchaseCommon Stock 1,895 $66.87 $126,718.65
Disclosure

SEC source: 0001628280-25-027340 · wk-form4_1747948827.xml · nonDerivative · entry 1

Desjardins Clarissa · CIK 0001793390 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 1,895

F1 · price: This is the weighted average purchase price representing 1,895 shares purchased at prices ranging from $66.75 to $66.98 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,830 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · derivative · entry 9

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 163,990

Underlying: Common Stock · 6,830 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F8 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 1,716 $68.54 $117,614.64
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 233,924

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · price: This is the weighted average sales price representing 1,716 shares sold at prices ranging from $68.50 to $68.59 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 2,251 $68.13 $153,360.63
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 6

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 235,640

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · price: This is the weighted average sales price representing 2,251 shares sold at prices ranging from $67.49 to $68.47 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 2,863 $66.90 $191,534.70
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 5

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 237,891

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · price: This is the weighted average sales price representing 2,863 shares sold at prices ranging from $66.42 to $67.35 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 6,830 $10.85 $74,105.50
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 7,088 $68.49 $485,457.12
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 314,230

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 7,088 shares sold at prices ranging from $68.38 to $68.59 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 4,480 $67.96 $304,460.80
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 321,318

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 4,480 shares sold at prices ranging from $67.38 to $68.37 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 20, 2025 Filed May 22, 2025 21:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 9,489 $66.87 $634,529.43
Disclosure

SEC source: 0001628280-25-027339 · wk-form4_1747948703.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 325,798

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 9,489 shares sold at prices ranging from $66.34 to $67.32 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 16, 2025 Filed May 19, 2025 21:05 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 1,799 $67.53 $121,486.47
Disclosure

SEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · nonDerivative · entry 3

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,797

F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:06 UTC
Bonstein SaraChief Financial Officer
GrantStock Option (right to buy) · Derivative 31,610 $0.00 Strike: $67.22 $0.00
Disclosure

SEC source: 0001628280-25-026586 · wk-form4_1747688783.xml · derivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,610

Underlying: Common Stock · 31,610 shares

Expires 2035-05-15

F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:06 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock 6,508 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-026586 · wk-form4_1747688783.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,867

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:06 UTC
Adsett RogerChief Operating Officer
GrantStock Option (right to buy) · Derivative 31,610 $0.00 Strike: $67.22 $0.00
Disclosure

SEC source: 0001628280-25-026585 · wk-form4_1747688771.xml · derivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,610

Underlying: Common Stock · 31,610 shares

Expires 2035-05-15

F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:06 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock 6,508 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-026585 · wk-form4_1747688771.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,183

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:06 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantStock Option (right to buy) · Derivative 27,100 $0.00 Strike: $67.22 $0.00
Disclosure

SEC source: 0001628280-25-026584 · wk-form4_1747688760.xml · derivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,100

Underlying: Common Stock · 27,100 shares

Expires 2035-05-15

F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:06 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantCommon Stock 5,578 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-026584 · wk-form4_1747688760.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,221

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:05 UTC
Lewis WilliamDirector · Chair and CEO
GrantStock Option (right to buy) · Derivative 108,380 $0.00 Strike: $67.22 $0.00
Disclosure

SEC source: 0001628280-25-026583 · wk-form4_1747688749.xml · derivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,380

Underlying: Common Stock · 108,380 shares

Expires 2035-05-15

F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:05 UTC
Lewis WilliamDirector · Chair and CEO
GrantCommon Stock 22,314 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-026583 · wk-form4_1747688749.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,287

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:05 UTC
Flammer Martina M.D.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 31,610 $0.00 Strike: $67.22 $0.00
Disclosure

SEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · derivative · entry 4

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,610

Underlying: Common Stock · 31,610 shares

Expires 2035-05-15

F5 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:05 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 9,925 $65.47 $649,789.75
Disclosure

SEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,596

F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 9,925 shares sold at prices ranging from $65.32 to $65.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:05 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 6,508 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-026581 · wk-form4_1747688735.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,521

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:05 UTC
Smith Michael AlexanderChief Legal Officer
GrantStock Option (right to buy) · Derivative 27,100 $0.00 Strike: $67.22 $0.00
Disclosure

SEC source: 0001628280-25-026580 · wk-form4_1747688723.xml · derivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,100

Underlying: Common Stock · 27,100 shares

Expires 2035-05-15

F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:05 UTC
Smith Michael AlexanderChief Legal Officer
GrantCommon Stock 5,578 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-026580 · wk-form4_1747688723.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,372

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:57 UTC GrantCommon Stock 5,058 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-026569 · wk-form4_1747688264.xml · nonDerivative · entry 1

Brennan David R · CIK 0001609305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,933

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:57 UTC GrantCommon Stock 5,058 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-026568 · wk-form4_1747688254.xml · nonDerivative · entry 1

SCHAFER CAROL · CIK 0001272181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,317

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:57 UTC GrantCommon Stock 5,058 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-026567 · wk-form4_1747688244.xml · nonDerivative · entry 1

Desjardins Clarissa · CIK 0001793390 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,007

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:57 UTC GrantCommon Stock 5,058 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-026566 · wk-form4_1747688232.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,216

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:57 UTC GrantCommon Stock 5,058 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-026565 · wk-form4_1747688222.xml · nonDerivative · entry 1

ANDERSON ELIZABETH M · CIK 0001758247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,729

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:56 UTC GrantCommon Stock 5,058 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-026564 · wk-form4_1747688210.xml · nonDerivative · entry 1

MCGIRR DAVID W J · CIK 0001219023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,973

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:56 UTC
LEE LEODirector
GrantCommon Stock 5,058 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-026563 · wk-form4_1747688199.xml · nonDerivative · entry 1

LEE LEO · CIK 0001740789 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,677

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

F2 · price: Each RSU was granted on May 15, 2025 for no consideration.

Read SEC document
May 14, 2025 Filed May 15, 2025 20:36 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 409 $65.61 $26,834.49
Disclosure

SEC source: 0001628280-25-025995 · wk-form4_1747341358.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,794

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.